| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $607.6M | +9.6% |
| Cost of Revenue | $111.5M | +3.7% |
| Gross Profit | $496.1M | +11.0% |
| R&D Expense | $111.9M | +1.2% |
| SG&A Expense | $68.7M | +11.3% |
| Operating Income | $187.2M | +14.8% |
| Pre-tax Income | $209.8M | +17.4% |
| Income Tax | $36.1M | +33.6% |
| Net Income | $173.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.2M | +14.0% |
| Accounts Receivable | $164.6M | +12.5% |
| Current Assets | $585.7M | -2.4% |
| Total Assets | $973.5M | +19.8% |
| Current Liabilities | $428.4M | +10.1% |
| Total Liabilities | $496.4M | +11.7% |
| Stockholders' Equity | $477.1M | +29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $244.1M | -0.2% |
| Capital Expenditures | $12.3M | +40.4% |
| Investing Cash Flow | -$71.4M | +2.4% |
| Financing Cash Flow | -$145.7M | -2.9% |
| Free Cash Flow | $231.8M | -1.7% |
| +14.6% |
| EPS (Basic) | $4.72 | +14.8% |
| EPS (Diluted) | $4.65 | +15.4% |